Targeting the Epidermal Growth Factor Receptor in High-Grade Astrocytomas
β Scribed by Will R. Voelzke; W. Jeffery Petty; Glenn J. Lesser
- Book ID
- 107532015
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 187 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1527-2729
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The epidermal growth factor receptor (EGFR) has been shown to be a promising therapeutic target in head and neck cancer. Cetuximab, a monoclonal antibody against EGFR, has been approved in the United States for use with radiotherapy for head and neck squamous cell carcinoma. However, th
Epidermal growth factor (EGF) and transforming growth factor-alpha (TGFo0 are two closely related peptides that interact with cell-surface epidermal growth factor receptors (EGFR) to induce receptor tyrosine phosphorylation and activation of intracellular signal-transduction pathways. EGF appears to